By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Hemostemix Inc.

Hemostemix Inc. (HMTXF)

OTC Market Data in USD, Fundamentals in CAD
$0.07
-$0.01
-12.54%
Last Update: 3 Sept 2025, 19:51
$13.06M
Market Cap
-3.89
P/E Ratio (TTM)
Forward Dividend Yield
$0.03 - $0.29
52 Week Range

HMTXF Stock Price Chart

Explore Hemostemix Inc. interactive price chart. Choose custom timeframes to analyze HMTXF price movements and trends.

HMTXF Company Profile

Discover essential business fundamentals and corporate details for Hemostemix Inc. (HMTXF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

7 Jan 2016

Employees

CEO

Thomas A. Smeenk BA Hons

Description

Hemostemix Inc., a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of critical limb ischemia in Canada and the United States, as well as for the treatment of heart and peripheral arterial diseases. The company is also developing various types of cell products, such as synergetic cell populations and neural cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.

HMTXF Financial Timeline

Browse a chronological timeline of Hemostemix Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 28 May 2026

Upcoming earnings on 28 May 2026

Upcoming earnings on 27 Nov 2025

Earnings released on 29 Aug 2025

Earnings released on 30 May 2025

EPS came in at -$0.01 .

Earnings released on 29 Apr 2025

EPS came in at -$0.02 .

Earnings released on 27 Nov 2024

EPS came in at -$0.01 .

Earnings released on 29 Aug 2024

EPS came in at -$0.00 .

Earnings released on 30 May 2024

EPS came in at -$0.00 .

Earnings released on 25 Mar 2024

EPS came in at -$0.01 .

Earnings released on 29 Nov 2023

EPS came in at -$0.00 .

Earnings released on 29 Aug 2023

EPS came in at -$0.00 .

Earnings released on 29 May 2023

EPS came in at -$0.01 .

Earnings released on 31 Dec 2022

EPS came in at -$0.01 .

Earnings released on 29 Nov 2022

EPS came in at -$0.01 .

Earnings released on 26 Sept 2022

EPS came in at -$0.02 .

Earnings released on 30 Aug 2022

EPS came in at -$0.02 .

Earnings released on 31 Dec 2021

EPS came in at -$0.04 .

Earnings released on 30 Sept 2021

EPS came in at -$0.01 .

Earnings released on 30 Jun 2021

EPS came in at -$0.02 .

Earnings released on 31 Mar 2021

EPS came in at -$0.01 .

Stock split effective on 5 Jan 2021

Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 Dec 2020

EPS came in at -$0.08 .

Stock split effective on 30 Dec 2020

Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 30 Sept 2020

EPS came in at -$0.03 .

HMTXF Stock Performance

Access detailed HMTXF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run